Back to Search
Start Over
Intranasal drug delivery of sumatriptan succinate-loaded polymeric solid lipid nanoparticles for brain targeting
- Source :
- Drug development and industrial pharmacy. 48(1)
- Publication Year :
- 2022
-
Abstract
- Migraine is a frequent neurological condition characterized by throbbing headaches, nausea, photophobia, and phonophobia, among other symptoms. Sumatriptan belongs to a BCS class III, which exhibits poor oral bioavailability and several side-effects. The objective of the present study was to develop solid lipid nanoparticles (SLNPs) of sumatriptan succinate for brain targeting by nasal route. Solvent injection method was used to increase the entrapment efficiency of hydrophilic drug. Thus, formulation was optimized by central composite design with minimum particle size, optimized zeta potential, and maximum entrapment efficiency, which was found to be 133.4 nm, -17.7 mV, and 75.5%, respectively. Optimized batch was further evaluated for surface morphology, Fourier-transform infrared spectroscopy
Details
- ISSN :
- 15205762
- Volume :
- 48
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Drug development and industrial pharmacy
- Accession number :
- edsair.doi.dedup.....fc19cbf430ef77c079a07607fd4b9628